# A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

> **NCT06208878** · — · ENROLLING_BY_INVITATION · sponsor: **CRISPR Therapeutics AG** · enrollment: 70 (estimated)

## Conditions studied

- Hematologic Malignancy
- Solid Malignancy

## Interventions

- **OTHER:** Non Interventional

## Key facts

- **NCT ID:** NCT06208878
- **Lead sponsor:** CRISPR Therapeutics AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-11-22
- **Primary completion:** 2038-08
- **Final completion:** 2038-08
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06208878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06208878, "A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06208878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*